KTKota Toshimoto
Kota Toshimoto
*This is an algorithmically generated author record based on publicly available information.
Kota Toshimoto has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Kazuya Maeda
School of Pharmacy, Kitasato University, Tokyo, Japan
1 shared publication - Kenta Hashizume
Drug Development Solutions Division, Sekisui Medical Co., Ltd, 2117 Muramatsu, Tokai, Ibaraki 319-1182, Japan
1 shared publication - Kiyomi Ito
Research Institute of Pharmaceutical Sciences, Musashino University, Tokyo, Japan
1 shared publication Koji Chiba
Sugiyama Laboratory, RIKEN Innovation Center, RIKEN, Yokohama, Japan; Clinical Pharmacology Research Laboratory, Yokohama University of Pharmacy, Yokohama, Japan
1 shared publication- Ryo Fujino
Drug Development Solutions Division, Sekisui Medical Co., Ltd, 2117 Muramatsu, Tokai, Ibaraki 319-1182, Japan
1 shared publication - Shin-Ichi Ninomiya
Drug Development Solutions Division, Sekisui Medical Co., Ltd, 2117 Muramatsu, Tokai, Ibaraki 319-1182, Japan
1 shared publication
Latest Publications
- 1 December 2018
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 125, 181-192
Strategies to improve the prediction accuracy of hepatic intrinsic clearance of three antidiabetic drugs: Application of the extended clearance concept and consideration of the effect of albumin on CYP2C metabolism and OATP1B-mediated hepatic uptake
- 1 December 2018
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 125, 181-192
Strategies to improve the prediction accuracy of hepatic intrinsic clearance of three antidiabetic drugs: Application of the extended clearance concept and consideration of the effect of albumin on CYP2C metabolism and OATP1B-mediated hepatic uptake
- 1 September 2017
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 106 (9) , 2727-2738
Analysis of the Change in the Blood Concentration-Time Profile Caused by Complex Drug–Drug Interactions in the Liver Considering the Enterohepatic Circulation: Examining Whether the Inhibition Constants for Uptake, Metabolism, and Biliary Excretion Can be Recovered by the Analyses Using Physiologically Based Pharmacokinetic Modeling
- 1 September 2017
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 106 (9) , 2727-2738
Analysis of the Change in the Blood Concentration-Time Profile Caused by Complex Drug–Drug Interactions in the Liver Considering the Enterohepatic Circulation: Examining Whether the Inhibition Constants for Uptake, Metabolism, and Biliary Excretion Can be Recovered by the Analyses Using Physiologically Based Pharmacokinetic Modeling